Lung Cancer News and Research

Latest Lung Cancer News and Research

Long-term night shift work among women may increase risk of cancers

Night shift work was associated with women having an increased risk of breast, skin, and gastrointestinal cancer, according to a meta-analysis.

8 Jan 2018

Researchers discover genetic mechanism for resistance to immunotherapy drugs

An urgent question for cancer scientists is why immunotherapy achieves dramatic results in some cases but doesn't help most patients.

5 Jan 2018

Cancer death rate continues decades-long drop in the United States

The cancer death rate dropped 1.7% from 2014 to 2015, continuing a drop that began in 1991 and has reached 26%, resulting in nearly 2.4 million fewer cancer deaths during that time.

4 Jan 2018

Small-cell lung cancer patients encounter obstacles to receiving standard-of-care treatment

Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the initial management of non-metastatic small-cell lung cancer (SCLC), a large percentage of U.S. patients do not receive these treatments and in turn have lower overall survival, according to research from The University of Texas MD Anderson Cancer Center.

4 Jan 2018

Experimental diabetes drugs can make cancer cells vulnerable to chemotherapy agents

Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more vulnerable to traditional chemotherapy agents, and they say such combinations should be explored to potentially improve outcomes for cancer patients.

2 Jan 2018

Experts report new guidelines for clinical trial design in patients with brain metastases

Clinical trials of new anti-cancer therapies have often excluded patients whose disease has spread to the brain or central nervous system (CNS) or, if such patients were allowed on trial, trials have often failed to clearly capture information on the drug's effect in the brain.

30 Dec 2017

Nanobiotix receives FDA approval for first immuno-oncology trial

NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).

26 Dec 2017

Higher ‘mutational burden’ of tumors predicts success rate with cancer immunotherapies

The "mutational burden," or the number of mutations present in a tumor's DNA, is a good predictor of whether that cancer type will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors, a new study led by Johns Hopkins Kimmel Cancer Center researchers shows.

21 Dec 2017

Diet rich in tomatoes and apples may help restore lung damage caused by smoking

A study from the Johns Hopkins Bloomberg School of Public Health found the natural decline in lung function over a 10-year period was slower among former smokers with a diet high in tomatoes and fruits, especially apples, suggesting certain components in these foods might help restore lung damage caused by smoking.

21 Dec 2017

Study explores use of radiosurgery in lung cancer patients with multiple brain metastases

Although targeted therapies have produced dramatic advances in our ability to control some types of advanced lung cancer, growth of the disease in the brain remains a major problem.

19 Dec 2017

Researchers uncover THOR gene involved in cancer development

It turns out Thor, the Norse god of thunder and the Marvel superhero, has special powers when it comes to cancer too.

15 Dec 2017

Radiation therapy can be used to treat patients with life-threatening heart rhythm

Radiation therapy often is used to treat cancer patients. Now, doctors at Washington University School of Medicine in St. Louis have shown that radiation therapy - aimed directly at the heart -; can be used to treat patients with a life-threatening heart rhythm.

14 Dec 2017

Targeted lung cancer treatments may benefit smokers and non-smokers alike

Smokers are less likely than non-smokers to have lung cancers caused by targetable genetic changes. But a study published this week in the journal Clinical Cancer Research shows that when they do, smokers benefit just as much as non-smokers from targeted treatments.

13 Dec 2017

Study finds rural-urban disparities in prevalence of dementia and cognitive impairment among seniors

Americans who live in urban areas tend to be healthier than individuals living in rural settings. While this healthcare disparity has been examined for more than a decade, researchers present the first nationally representative study to find that dementia and cognitive impairment have consistently been more prevalent among rural-dwelling seniors than urban dwelling seniors.

12 Dec 2017

New first line combination therapy shows promising results in patients with advanced NSCLC

A new combination therapy for the first line treatment of advanced non-squamous non-small-cell lung cancer (NSCLC) improves progression-free survival (PFS), according to results of phase III IMpower150 trial presented at the ESMO Immuno Oncology Congress 2017.

7 Dec 2017

Immune-boosting drug combination may hold promise for treating ovarian cancer

Johns Hopkins Kimmel Cancer Center researchers demonstrated that mice with ovarian cancer that received drugs to reactivate dormant genes along with other drugs that activate the immune system had a greater reduction of tumor burden and significantly longer survival than those that received any of the drugs alone.

5 Dec 2017

Novel drug combination could enhance immunotherapy responses in patients with lung cancer

Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy.

30 Nov 2017

New software could make real-time DNA-authentication a reality

In the science-fiction movie Gattaca, visitors only clear security if a blood test and readout of their genetic profile matches the sample on file. Now, cheap DNA sequencers and custom software could make real-time DNA-authentication a reality.

30 Nov 2017

'Aggressive' surgery for early stage lung cancer provides better outcomes

Patients with early stage lung cancer live longer when they receive a lobectomy- the most common type of operation for the disease- rather than a less extensive operation or radiation treatment, according to a study published online today in The Annals of Thoracic Surgery.

30 Nov 2017

Study: Fewer new cases of lung cancer found in communities with strong smoke-free laws

A recent study by University of Kentucky BREATHE researchers shows that fewer new cases of lung cancer were found in communities with strong smoke-free workplace laws.

29 Nov 2017

Lung Cancer News and Research

Latest Lung Cancer News and Research

Long-term night shift work among women may increase risk of cancers

Researchers discover genetic mechanism for resistance to immunotherapy drugs

Cancer death rate continues decades-long drop in the United States

Small-cell lung cancer patients encounter obstacles to receiving standard-of-care treatment

Experimental diabetes drugs can make cancer cells vulnerable to chemotherapy agents

Experts report new guidelines for clinical trial design in patients with brain metastases

Nanobiotix receives FDA approval for first immuno-oncology trial

Higher ‘mutational burden’ of tumors predicts success rate with cancer immunotherapies

Diet rich in tomatoes and apples may help restore lung damage caused by smoking

Study explores use of radiosurgery in lung cancer patients with multiple brain metastases

Researchers uncover THOR gene involved in cancer development

Radiation therapy can be used to treat patients with life-threatening heart rhythm

Targeted lung cancer treatments may benefit smokers and non-smokers alike

Study finds rural-urban disparities in prevalence of dementia and cognitive impairment among seniors

New first line combination therapy shows promising results in patients with advanced NSCLC

Immune-boosting drug combination may hold promise for treating ovarian cancer

Novel drug combination could enhance immunotherapy responses in patients with lung cancer

New software could make real-time DNA-authentication a reality

'Aggressive' surgery for early stage lung cancer provides better outcomes

Study: Fewer new cases of lung cancer found in communities with strong smoke-free laws

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in